Investors Aren’t Entirely Convinced By Ekso Bionics Holdings, Inc.’s (NASDAQ:EKSO) Revenues

You may think that with a price-to-sales (or “P/S”) ratio of 1.7x Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) is definitely a stock worth checking out, seeing as almost half of all the Medical Equipment companies in the United States have P/S ratios greater than 3.8x and even P/S above 9x aren’t out of the ordinary. Although, it’s not wise to just take the P/S at face value as there may be an explanation why it’s so limited.

View our latest analysis for Ekso Bionics Holdings


How Has Ekso Bionics Holdings Performed Recently?

Recent times have been advantageous for Ekso Bionics Holdings as its revenues have been rising faster than most other companies. It might be that many expect the strong revenue performance to degrade substantially, which has repressed the share price, and thus the P/S ratio. If not, then existing shareholders have reason to be quite optimistic about the future…

Read more…

Request a Call Back

Contact Info